Different Factors Associated with CTX-M-Producing ST131 and Non-ST131 Escherichia coli Clinical Isolates

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Nicolas Chanoine, Marie Hélène ^a,b,c   Robert, Jérôme ^d,e   Vigan, Marie ^f   Laouénan, Cédric ^f,g   Brisse, Sylvain ^h   Mentré, France ^f,g   Jarlier, Vincent ^d,e  

^a BEAUJON HOSPITAL   (France)

^b Faculte de Medecine D Diderot   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g BICHAT HOSPITAL   (France)

^h INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE CTX M; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANIMAL PRODUCT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FACTORIAL ANALYSIS; FEMALE; FOOD INTAKE; FRANCE; HEALTH CARE FACILITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POULTRY; STRAIN DIFFERENCE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

EID: 84883334712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072191     Document Type: Article

References (25)

1. Brisse S, Diancourt L, Laouenan C, Vigan M, Caro V, et al. (2012) Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J Clin Microbiol 50: 2974-2981.
2. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, et al. (2012) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 67: 346-356.
3. Kluytmans JA, Overdevest ITM, Willemsen I, Kluytmans-van den Bergh MF, van der Zwaluw K, et al. (2012) Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis 56: 478-487.
4. Nicolas-Chanoine M-H, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, et al. (2013) 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother 68: 562-568.
5. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, et al. (2011) Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 17: 1216-1222.
6. Egea P, Lopez-Cerero L, Torres E, Gomez-Sanchez Mdel C, Serrano L, et al. (2012) Increased raw poultry meat colonization by extended-spectrumβ-lactamase-producing Escherichia coli in the south of Spain. Int J Food Microbiol 159: 69-73.
7. Mora A, Herrera A, Mamani R, Lopez C, Alonso MP, et al. (2010) Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl Environ Microbiol 76: 6991-6997.
8. Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, et al. (2010) Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis 16: 88-95.
9. Mora A, Lopez C, Herrera A, Viso S, Mamani R, et al. (2012) Emerging avian pathogenic Escherichia coli strains belonging to clonal groups O111:H4-D-ST2085 and O111:H4-D-ST117 with high virulence-gene content and zoonotic potential. Vet Microbiol 156: 347-352.
10. Nicolas-Chanoine MH, Jarlier V, Robert J, Arlet G, Drieux L, et al. (2012) Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study. PLoS ONE 7: e30498.
11. Johnson J, R, Menard E, Johnston B, Kuskowski MA, Nichol KA, et al. (2009) Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53: 2733-2739.
12. Rogers BA, Sidjabat HE, Paterson DL, (2011) Escherichia coli 025b-ST131: a pandemic multiresistant, community-associated strain. J Antimicrob Chemother 66: 1-14.
13. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E, (2012) Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 80: 1554-1562.
14. Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, et al. (2012) Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS ONE 7: e34294.
15. Vimont S, Boyd A, Bleibtreu A, Bens M, Goujon JM, et al. (2012) The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS ONE 7: e46547.
16. Manges AR, Johnson JR, (2012) Food-borne origins of Escherichia coli causing extra-intestinal infections Clin Infect Dis. 55: 712-719.
17. Dhanji H, Murphy NM, Doumith M, Durmus S, Lee SS, et al. (2010) Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK. J Antimicrob Chemother 65: 2534-2537.
18. Cohen Stuart J, van den Munckhof T, Voets G, Scharringa J, Fluit A, et al. (2012) Comparison of ESBL contamination in organic and conventional retail chicken meat. Int J Food Microbiol 154: 212-214.
19. Cortes P, Blanc V, Mora A, Dahbi G, Blanco JE, et al. (2010) Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl Environ Microbiol 76: 2799-2805.
20. Guenther S, Aschenbrenner K, Stamm I, Bethe A, Semmler T, et al. (2012) Comparable high rates of extended-spectrum-β-lactamase-producing Escherichia coli in birds of prey from Germany and Mongolia. PLoS ONE 7: e53039.
21. Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, et al. (2009) Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 64: 635-641.
22. Kassis-Chikhani N, Vimont S, Asselat K, Trivalle C, Minassian B, et al. (2004) CTX-M β-lactamase-producing Escherichia coli in long-term care facilities, France. Emerg Infect Dis 10: 1697-1698.
23. Leflon-Guibout V, Jurand C, Bonacorsi S, Espinasse F, Guelfi MC, et al. (2004) Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 48: 3736-3742.
24. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, et al. (2013) Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 34: 361-369.
25. Peirano G, Laupland KB, Gregson DB, Pitout JD, (2011) Colonization of returning travellers with CTX-M-producing Escherichia coli. J Travel Med 18: 299-303.